TMCI Investors Have Final Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, June 9, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ: TMCI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May 8, 2023 and May 7, 2024, inclusive (the "Class Period"), ...